Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
Innovations in Actinic Keratosis
Rawlings E Lyle1, Linh H Tran1, Daniel B Eisen2
1Department of Dermatology, University of California, Davis School of Medicine, 4610 X Street, Sacramento, CA 95817, USA.
Abstract:
This review discusses recent progress in actinic keratosis (AK) management, highlighting therapeutic breakthroughs, pathophysiological discoveries, and program implementation strategies. This article also explores advances in photodynamic therapy, introduces new topical treatments, and details the genomic and transcriptomic pathways from AK to squamous cell carcinoma, including the role of the cutaneous microbiome. Studies aiming to improve diagnosis, adherence, and patient-focused care are also reviewed. Together, these insights encourage a move toward personalized, technology-enhanced approaches in AK treatment, aiming to better patient outcomes and prevent the escalation to more severe skin cancers.
Insights
Recent advancements in actinic keratosis (AK) management include new therapies and understanding of disease progression. Personalized, technology-enhanced approaches aim to improve patient outcomes and prevent skin cancer.
Area of Science:
- Dermatology and Oncology
- Molecular Biology
- Microbiology
Background:
- Actinic keratosis (AK) is a common precursor to squamous cell carcinoma.
- Effective management and early detection are crucial for preventing cancer progression.
Purpose of the Study:
- To review recent therapeutic breakthroughs and pathophysiological discoveries in AK management.
- To explore advances in photodynamic therapy and new topical treatments.
- To detail genomic and transcriptomic pathways from AK to squamous cell carcinoma, including microbiome roles.
Main Methods:
- Literature review of recent studies on AK management.
- Analysis of therapeutic innovations and diagnostic improvements.
- Examination of molecular pathways and microbiome influence.
Main Results:
- Highlighting novel treatments and improved diagnostic strategies.
- Elucidating the genomic and transcriptomic landscape of AK progression.
- Emphasizing the role of the cutaneous microbiome in AK development.
Conclusions:
- Current insights support personalized, technology-enhanced AK treatment strategies.
- Improved patient care and adherence are key to better outcomes.
- Preventing AK progression to squamous cell carcinoma remains a primary goal.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Clinical Applications of Epidermal Stem Cells
Renewal of Skin Epidermal Stem Cells
Tumor Immunotherapy
iPS Cell Differentiation

